Literature DB >> 22052931

The epidemiology of vascular dysfunction relating to chronic obstructive pulmonary disease and emphysema.

R Graham Barr1.   

Abstract

Cor pulmonale has long been described in very severe chronic obstructive pulmonary disease (COPD) and emphysema. Cross-sectional results from population-based studies show that left ventricular filling and a variety of vascular measures in the systemic circulation are abnormal in preclinical COPD and emphysema and that a predominant vascular change in COPD and emphysema is endothelial and microvascular dysfunction. These findings suggest that pulmonary vascular changes may occur early in COPD and emphysema and might contribute to pathogenesis. However, longitudinal epidemiologic studies with direct measures of the pulmonary vasculature are lacking; therefore, inferences are limited at present. New imaging-based approaches to the assessment of the pulmonary vasculature are applicable to epidemiologic studies and may help in defining the relationship of pulmonary vascular damage to progression of COPD and emphysema. These measures may also provide imaging-based surrogate markers, and novel therapeutics targeted to the pulmonary vasculature might reduce symptoms and improve function in these common diseases.

Entities:  

Mesh:

Year:  2011        PMID: 22052931      PMCID: PMC3359073          DOI: 10.1513/pats.201101-008MW

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  60 in total

1.  Risk factor-gene interaction in carotid atherosclerosis: effect of gene polymorphisms of renin-angiotensin system.

Authors:  Y Tabara; K Kohara; J Nakura; T Miki
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

2.  Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.

Authors:  Hans L Hillege; Vaclav Fidler; Gilles F H Diercks; Wiek H van Gilst; Dick de Zeeuw; Dirk J van Veldhuisen; Rijk O B Gans; Wilbert M T Janssen; Diederick E Grobbee; Paul E de Jong
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

Review 3.  Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology.

Authors:  David P Faxon; Valentin Fuster; Peter Libby; Joshua A Beckman; William R Hiatt; Robert W Thompson; James N Topper; Brian H Annex; John H Rundback; Rosalind P Fabunmi; Rose Marie Robertson; Joseph Loscalzo
Journal:  Circulation       Date:  2004-06-01       Impact factor: 29.690

4.  Left ventricular function, metabolism, and blood flow in chronic cor pulmonale.

Authors:  M J Frank; A B Weisse; C B Moschos; G E Levinson
Journal:  Circulation       Date:  1973-04       Impact factor: 29.690

5.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Authors:  H C Gerstein; J F Mann; Q Yi; B Zinman; S F Dinneen; B Hoogwerf; J P Hallé; J Young; A Rashkow; C Joyce; S Nawaz; S Yusuf
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

6.  Right ventricular failure following chronic pressure overload is associated with reduction in left ventricular mass: evidence for atrophic remodeling.

Authors:  Maxim Hardziyenka; Maria E Campian; Herre J Reesink; Sulaiman Surie; Berto J Bouma; Maarten Groenink; Christine A Klemens; Leander Beekman; Carol A Remme; Paul Bresser; Hanno L Tan
Journal:  J Am Coll Cardiol       Date:  2011-02-22       Impact factor: 24.094

7.  Enhanced expression of vascular endothelial growth factor in pulmonary arteries of smokers and patients with moderate chronic obstructive pulmonary disease.

Authors:  Salud Santos; Victor I Peinado; Josep Ramirez; Jaime Morales-Blanhir; Ricardo Bastos; Josep Roca; Robert Rodriguez-Roisin; Joan A Barbera
Journal:  Am J Respir Crit Care Med       Date:  2003-02-20       Impact factor: 21.405

8.  Microalbuminuria in chronic obstructive pulmonary disease.

Authors:  A Kömürcüoğlu; S Kalenci; D Kalenci; B Kömürcüoğlu; G Tibet
Journal:  Monaldi Arch Chest Dis       Date:  2003 Oct-Dec

9.  Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging.

Authors:  Jonathan R Panting; Peter D Gatehouse; Guang-Zhong Yang; Frank Grothues; David N Firmin; Peter Collins; Dudley J Pennell
Journal:  N Engl J Med       Date:  2002-06-20       Impact factor: 91.245

Review 10.  Pulmonary hypertension in chronic obstructive pulmonary disease.

Authors:  J A Barberà; V I Peinado; S Santos
Journal:  Eur Respir J       Date:  2003-05       Impact factor: 16.671

View more
  13 in total

Review 1.  Pathophysiology and clinical evaluation of acute heart failure.

Authors:  Robert J Mentz; Christopher M O'Connor
Journal:  Nat Rev Cardiol       Date:  2015-09-15       Impact factor: 32.419

2.  U-shaped association between body mass index and proteinuria in a large Japanese general population sample.

Authors:  Yuji Sato; Shouichi Fujimoto; Tsuneo Konta; Kunitoshi Iseki; Toshiki Moriyama; Kunihiro Yamagata; Kazuhiko Tsuruya; Hideaki Yoshida; Koichi Asahi; Issei Kurahashi; Yasuo Ohashi; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2013-05-08       Impact factor: 2.801

3.  Pulmonary vascular density: comparison of findings on computed tomography imaging with histology.

Authors:  Farbod N Rahaghi; Gemma Argemí; Pietro Nardelli; David Domínguez-Fandos; Pedro Arguis; Víctor I Peinado; James C Ross; Samuel Y Ash; Isaac de La Bruere; Carolyn E Come; Alejandro A Diaz; Marcelo Sánchez; George R Washko; Joan Albert Barberà; Raúl San José Estépar
Journal:  Eur Respir J       Date:  2019-08-15       Impact factor: 16.671

4.  Effect of culture conditions on microRNA expression in primary adult control and COPD lung fibroblasts in vitro.

Authors:  Jun Ikari; Lynette M Smith; Amy J Nelson; Shunichiro Iwasawa; Yoko Gunji; Maha Farid; Xingqi Wang; Hesham Basma; Carol Feghali-Bostwick; Xiangde Liu; Dawn L DeMeo; Stephen I Rennard
Journal:  In Vitro Cell Dev Biol Anim       Date:  2015-01-01       Impact factor: 2.416

Review 5.  Pulmonary CT and MRI phenotypes that help explain chronic pulmonary obstruction disease pathophysiology and outcomes.

Authors:  Eric A Hoffman; David A Lynch; R Graham Barr; Edwin J R van Beek; Grace Parraga
Journal:  J Magn Reson Imaging       Date:  2015-07-22       Impact factor: 4.813

Review 6.  Cardiopulmonary coupling in chronic obstructive pulmonary disease: the role of imaging.

Authors:  Farbod N Rahaghi; Edwin J R van Beek; George R Washko
Journal:  J Thorac Imaging       Date:  2014-03       Impact factor: 3.000

7.  Morpho-Functional 1H-MRI of the Lung in COPD: Short-Term Test-Retest Reliability.

Authors:  Bertram J Jobst; Mark O Wielpütz; Simon M F Triphan; Angela Anjorin; Julia Ley-Zaporozhan; Hans-Ulrich Kauczor; Jürgen Biederer; Sebastian Ley; Oliver Sedlaczek
Journal:  PLoS One       Date:  2015-09-01       Impact factor: 3.240

8.  Statins Dose-Dependently Exert Significant Chemopreventive Effects Against Various Cancers in Chronic Obstructive Pulmonary Disease Patients: A Population-Based Cohort Study.

Authors:  Chun-Chao Chen; Yi-Ping Hsu; Ju-Chi Liu; Pai-Feng Kao; Li-Chin Sung; Chao-Feng Lin; Wen-Rui Hao; Shing-Hwa Liu; Szu-Yuan Wu
Journal:  J Cancer       Date:  2016-09-13       Impact factor: 4.207

9.  Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study.

Authors:  Ju-Chi Liu; Wen-Rui Hao; Yi-Ping Hsu; Li-Chin Sung; Pai-Feng Kao; Chao-Feng Lin; Alexander T H Wu; Kevin Sheng-Po Yuan; Szu-Yuan Wu
Journal:  Oncotarget       Date:  2016-10-04

10.  Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study.

Authors:  Ju-Chi Liu; Tsung-Yeh Yang; Yi-Ping Hsu; Wen-Rui Hao; Pai-Feng Kao; Li-Chin Sung; Chun-Chao Chen; Szu-Yuan Wu
Journal:  Oncotarget       Date:  2016-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.